Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

PCO Prevalance in adolescents with menstrual irregularity

Author
Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Abstract
This is a comparative cross – sectional prospective study with the aim of evaluation of prevalence and correlation between menstrual irregularity and PCO in postmenarcheal age. This evaluation has done in two groups of healthy adolescent girls 12-19 years old who admitted in shahid Mostafa Khomeini hospital, IRIB Clinic and a private clinic. We compared 47 adolescent girls who had irregular menstruation (as study group) with 22 adolescent girls who had normal menses (as control group) We did abdominal ultrasonography (US) in both groups and evaluated US features of PCO on them .This research shows that PCO was seen to be more common in adolescent girls with menstrual irregularity (42/5% vs 13.6% , p<0.011) with a tendency to be more frequent in oligomenorrhea–amenorrhea group than in polymenorrhea (51.6%vs 25% P>0.08).We have also seen increased LH/FSH in 86.9% and abnormal androgens profiles in 69.5% in girls with PCO. These results suggest that US changes compatible with PCO is a frequent finding in adolescent girls with menstrual disturbance preferably in those with oligoamenorreha
Keywords

Read G.,Wilson D., Hughes I., et al. The use of salivary progestrone assays in the assesment of ovarian function in post menarcheal girls. J Endocrinol. 1984; 102:265
Largo R.H., Prader A. Pubertal developments in girls, viriability and inter relationship. Pediatrician. 1987; 14:212-218
Borsos A., lamp R., Balogh A., et al. Ovarian function after the menarehe and hormonal contraception. Int J Obs Gyn. 1988; 27:249-253
Goldziehre J.W., Axelord L.R. Clinical and biocemical features of polycystic ovarian disease. Fertil Steril. 1963; 14:631-653
Balen A.H., Conway G.S., Kartsas G., et al. Polycystic ovary syndromes the spectrum of the disorder in 1741 patients. Hum Reprod. 1995; 10:2107-2111
Stein I.F., Leventhal M.L. Amenorrhea associated with bilateral polycystic ovaries. Am J Obs Gyn 1935; 29:181-191
Pasquali R. Casimirrif. The impact of obesity on hyperandrogenism and polyaystic ovary syndrome in premenopausal women. Clin Endocrinol (oaford) 1993; 39:-16
Lobo R.A., Gobels mannu., Horton R. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. Clin Endocrinol Metab 1983;57:393-397
Santoro N.F., Tortoriello D.V. Amenorrhea: etiology and therapies. In: int. Frontiers in Reproductive endocrinolgy. Serono symposia USA Inc. 1999; 307-330
Deziegler D., Steungold K., Cedars M., et al. Recovery of hormon secretion after chronic gonadotropin-Releasing hormon agonist administration in women with PCO disease. J. Clin Endocrinol Metab. 1989; 68,111-7
Goldzieher J.W., Axelrod L.R. Clinical and biochemical features of polycystic ovarian disease Fertil Steril 1963; 14:631-653
Van Hoof voorhorst F.J., Katein M,B. Hirasing R.A., et al. Endocrine features of polycystic ovary syndrome in a Random population sample of 14-16 years old adolescents. Hum Reprod. 1999; 14(9):2223-9
Michelmore K.F., Baren A.H., Dunger D.B., et al. Polycystic ovaries and associated clinical and biochemical features in young women. ClinEndocrinol. 1999; 31(6):779-89
Lobo R.A., Kletzky O.A., Cameau J.D., et al.Elevated bioactive LH in women with polycytic ovary syndromee. Fertil Steril 1903;39:674-678. 15. Balen A.H., Conway G.S., Kaltsas G., et al. Polycysitc ovary syndrome: the spectrum of the clinical disorder in 1741 patients. Hum Reprod 1995;10:2107-2111
Van Hoof M.H.,Voorhorst F.J., Kaptein M.B., et al. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormon, androgens and insulin. Fertil Steril. 2000; 74(1): 49-58
Apter D. How possible is the prevention of PCO develope in adolescent patients with early onset of hyperandrogenism. Endocrinol Invest. 1998; 21(9): 613-7
Carmina E., Koyama T., Chang L., et al. Does Ethnicity influence the prevalence of aelrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome. Am J Obs Gyn 1992; 167:1807-1812